You will not be allowed to compare more than 4 products at a time
View compareWhat is Betnovate Scalp Application?
Betnovate Scalp Application, a prescription-only dermatological medication, is produced by GlaxoSmithKline UK to address scalp-related skin conditions like eczema and psoriasis. Its key component is betamethasone valerate 0.1%, a corticosteroid with anti-inflammatory properties that aid in soothing irritated skin. Administered twice daily to dry, flaky, or inflamed areas, it effectively alleviates redness, itching, and irritation. It's recommended for use alongside scalp moisturisers and emollients to manage scalp eczema.
What is Betnovate Scalp Application used to treat?
Betnovate serves as a remedy for itchy scalp conditions like atopic eczema and seborrheic dermatitis that can cause irritation and discomfort.
As a potent steroid medication, it is prescribed on a short-term basis to quickly and effectively alleviate the redness, itching, and irritation commonly associated with scalp conditions.
Who can and cannot use medicines containing Betnovate?
Betnovate Scalp Application is generally well-tolerated. However, it is important to consider the following before usage:
Avoid using Betnovate if:
-
you have an allergy to betamethasone valerate or any other components in this product
-
you are dealing with a scalp skin infection
-
you intend to use Betnovate on children under 1 year old
Consult your doctor or pharmacist before using this product if:
-
you plan to apply it over a large surface area
-
you are pregnant or breastfeeding
-
you have psoriasis (regular monitoring by your doctor is necessary)
-
you have a history of allergic reactions to steroid medicines
-
you need to apply the liquid to skin folds or broken skin
-
you are applying the liquid under an airtight dressing
-
you are applying the liquid to children or areas with thin skin (children's skin is thinner and may absorb larger amounts).
If uncertain about the suitability of Betnovate for your specific situation, seek advice from your doctor.